The US federal government has taken a major step in cannabis policy. President Donald Trump signed an executive order moving marijuana to Schedule III under federal law.
Previously, marijuana was classified as a Schedule I drug, alongside heroin and LSD, considered highly addictive with no accepted medical use. This made federal restrictions strict, despite many US states legalizing medical and recreational cannabis.
Under Schedule III, marijuana is considered to have a “moderate to low potential for dependence.” This change allows broader medical use, easier banking access, and formal recognition of cannabis in healthcare.
The US cannabis industry has grown rapidly in recent years but has operated in a legal grey zone. Federal restrictions limited banking access and complicated investment. The new classification could boost the industry’s stability and economic growth.
Critics, however, caution that modern cannabis products are much stronger than earlier forms. Public health advocates urge careful regulation to prevent underage use, impaired driving, and misuse alongside alcohol or other substances.
Supporters argue that keeping marijuana in the same category as heroin was unrealistic. They say reclassification could reduce black market activity, increase tax revenue, and give doctors better tools for treating chronic pain.
Investors and campaigners also highlight that moving marijuana into a fully legal and banked economy may weaken drug cartels and support economic growth in states with legalized cannabis.
In other related news also read Smuggling Bid Foiled as 2.19kg Marijuana Found at Karachi Airport
The US government’s move signals a historic shift in federal drug policy. While federal rules evolve, balancing economic benefits with public safety and health oversight will remain a key focus for policymakers and regulators.
